-
Money talks when it comes to infection prevention, particularly if it's coming out of your purse or wallet. That appears to be the lesson thus far of an infection control policy taken to an unusual extreme.
-
Although we cannot move away from rates of healthcare associated infections (HAIs) especially in this age of HAI public reporting and transparency health care professionals might need reminding that people are represented in any HAI data calculated, statistically analyzed or distributed.
-
A recently reported dramatic national reduction in central line associated blood stream infections (CLABSIs) puts a harsh light on hospitals that have not adopted a "checklist" protocol and other proven measures to fight infections that are both expensive and deadly.
-
In compiling national surveillance data on central line associated blood stream infections (CLABSIs) the Centers for Disease Control and Prevention made an interesting finding: Reductions in CLABSIs caused by Staphylococcus aureus were more marked than reductions in infections caused by gram-negative rods, such as Candida and Enterococcus.
-
For years HIV experts and advocates have warned that unless federal funding for the AIDS Drug Assistance Program (ADAP) was ramped up significantly then thousands of Americans could be left off the roles and face risks of illness and death without dependable access to antiretroviral therapy (ART).
-
The Centers for Disease Control and Prevention is developing formal guidelines on preexposure prophylaxis (PrEP) to prevent HIV in men who have sex with men (MSM). In the interim, the CDC has issued the following recommendations to guide clinical practice.
-
The once rare but very real risk of occupational HIV transmission continues to fade in the face of a host of prevention measures that include needle safety devices and post-exposure prophylaxis.
-
With unprecedented numbers of HIV patients pushed onto waiting lists to receive antiretroviral (ART) drugs from AIDS Drug Assistance Programs (ADAPs), the bottom rung safety nets are barely holding, experts say.
-
HIV clinicians are seeing increasing numbers of patients who are developing cancers associated with infectious agents, particularly in the areas of the oropharynx and genitals, researchers say.
-
While the human papillomavirus (HPV) vaccine has been approved for use in men, how many are open to receiving it? New research indicates men might be more willing to receive vaccination when they learn the vaccine can prevent cancer.
